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Early Diagnosis of Perioperative Myocardial Infarction
After Coronary Bypass Grafting: Why Is the Incidence
so High?
To the Editor:
We read with interest the article by Lim and colleagues [1], who
evaluated the possibility of the early diagnosis of perioperative
acute myocardial infarction (PAMI) after coronary artery bypass
grafting (CABG) using Troponin I (TnI) and cardiac magnetic
resonance imaging. In our opinion, a few remarks with respect to
the definitions and, therefore, to the results ought to be addressed.
In their series of 28 patients, the authors reported that 9
patients had a TnI value 7.5 ng/L early after on-pump CABG
and emphasized that it is 95% specific for detecting a PAMI. As
a consequence, CABG-related PAMI occurred in approximately
33% (9/28) of patients, which is an extremely high rate of events.
Moreover, it is noteworthy that all patients had an uneventful
recovery, did not require inotropic support or use of intraaortic
balloon pump, and did not have new Q waves or left bundle
branch block documented. Hence, it is our opinion that the
definition of PAMI may have been too extensive, and the
difference between PAMI and postoperative myocardial injury
(or myocardial damage) was not clearly defined.
In 2008 my colleagues and I [2], while evaluating the occur-
rence of postoperative release of biomarkers in a large series of
patients underwent on-pump CABG, showed that biomarker
levels were increased in 35% to 65% of patients in the first hours
after coronary surgery. However, according to current literature,
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evidence of PAMI or fulfilled the criteria for postoperative
diagnosis of PAMI [3]. As previously reported, high serum levels
of cardiac enzymes are common in more than 60% of patients
after on-pump coronary surgery, even in the absence of clinical,
electrocardiographic, and hemodynamic evidence of PAMI. This
myocardial damage can be caused by different mechanisms,
including direct trauma by sewing needles; focal trauma from
surgical manipulation of the heart; global ischemia from inade-
quate perfusion, myocardial cell protection, or anoxia; coronary
artery or venous graft embolism; and other complications of the
procedure. Having said that, we continue to believe that a
number of different criteria must be met for a PAMI to be
diagnosed: (1) indicative electrocardiographic changes (ST-T
changes, new Q-wave appearance, and reduction of R waves
greater than 25% in at least 2 contiguous leads); (2) echocardio-
graphic evidence of new akinetic or dyskinetic ventricular wall
segments; and (3) biochemical indicators (maximal concentra-
tion of TnI and maximal value of CK-MB mass exceeding
twofold the upper reference limits on two subsequent samples
or maximal value exceeding fivefold the normal reference limits
on one occasion). Upper reference limits for TnI have been
established at 0.08 ng/mL (the 99th percentile of referenced
controlled group with a total imprecision of 10%). Therefore,
the sole laboratory evidence of increased biomarker serum level
without evidence of the other two criteria is a soft outcome to
justify any aggressive treatment as necessary in case of PAMI.
Vito Mannacio, MD
Domenico Iorio, MD
Vincenzo De Amicis, MD
Department of Cardiac Surgery
University of Naples Federico II
Via Pansini, 5
Naples 80131, Italy
Fig 1. (A) Postoperative computed tomo-
graphic (CT) scan demonstrated that both
stent grafts were fitted in semicircular shape
within the patient’s abdominal aorta. (B) A
reconstructed CT scan disclosed that the two
stent-grafts paralleled each other and then
separated into each iliac artery.e-mail: vitomannacio2@libero.it
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Reply
To the Editor:
I am grateful to Mannacio and colleagues [1] for their interest in
the findings of our study. As they know, identifying myocardial
infarction (MI) related to coronary artery bypass grafting
(CABG) using conventional electrocardiography and biochemi-
cal methods is difficult. In our investigation we used late gado-
linium enhancement (LGE) cardiovascular magnetic resonance
imaging (CMR) and biomarkers of injury and inflammation to
investigate the incidence and early predictors of MI type 5 in
patients undergoing CABG [2].
Troponin is a particularly sensitive biomarker, and as they and
other investigators have demonstrated, troponin elevation is
common and could almost be regarded as normal early after
on-pump cardiac surgical procedures. Consequently, the diag-
nosis of CABG-related MI type 5 established by the joint task
force of the American College of Cardiology Foundation, the
American Heart Association, the European Society of Cardiol-
ogy, and the World Heart Federation requires biomarker values
more than five times the 99th percentile during the first 72 hours
after CABG, together with either the appearance of new patho-
logic Q-waves or new left bundle branch block, or angiographi-
cally documented new graft or native coronary artery occlusion,
or imaging evidence of new loss of viable myocardium [3].
In our study, the protocol involved routine imaging after the
procedure, and this imaging fundamentally changed the cate-
gorization of our patients. To put in an alternative way, if we had
not performed magnetic resonance imaging, the patient would
not have been categorized as having MI type 5 despite the same
clinical course and level of biomarker release! Highlighting this
anachronism was one of the purposes of the article, along with
a suggestion that initial biomarker release profiles may be
different in patients with evidence of necrosis on MRI postop-
eratively. Whether those patients should be categorized as
having CABG-related MI or CABG-related myocardial necrosis
can be debated. In my opinion, the latter is probably more
clinically appropriate, whereas the emotive term of CABG-
related MI is reserved for patients with clinically relevant
complications.
Adrian Banning, FRCP
Department of Cardiology
Oxford Heart Centre
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OPCAB Technique for High-Risk Patients
To the Editor:
I read with interest the article by Singh and colleagues [1]. They
describe a novel technique for performing off-pump coronary
artery bypass (OPCAB) in a patient with left main stem coronary
disease.
I have been doing OPCAB for the last 15 years and like most
of the other surgical groups, left main coronary artery disease
has never been considered a contraindication for OPCAB graft-
ing [2].
I have routinely used the glove technique in most of my
patients with very low ejection fraction and in unstable patients
with or without left main coronary artery disease. Instead of air,
I have used lukewarm saline, which provides an excellent
cushion and hemodynamic stability and keeps the heart warm.
In my series of almost 1200 cases, I have had two conversions
to on-pump bypass grafting using combined glove and deep
pericardial sling. The technique of using glove is well estab-
lished and is not a new, novel technique as described by the
authors [1].
Ashok Kumar Sharma, FRACS
Department of Cardiothoracic Surgery
Sultan Qaboos University Hospital
PO Box 35, Al-Khoud 123
Muscat, Oman
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Reply
To the Editor:
We read with interest the letter from Dr Sharma [1] regarding
our technique published in the previous issue of this journal as
“How to Do It” [2]. We thank the author for these interesting
comments and remarks.
However, I beg to differ from Dr Sharma’s statement that leftmain disease (LMD) has never been considered a contraindica-
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